CLINICAL AND EPIDEMIOLOGICAL FEATURES OF 210 COVID-19 PATIENTS IN BABYLON GOVERNORATE DURING 2020

Authors

  • Nawar Al-Janabi 1Department of Biotechnology, College of Biotechnology, Al-Qasim Green University, Babylon, Iraq.
  • Mohanad Jawad Public Health Laboratory, Babylon Health Department, Babylon, Iraq.
  • Abbas abed Sharhan Department of Biotechnology, College of Biotechnology, Al-Qasim Green University, Babylon, Iraq.
  • Zahraa M. Madani Department of Biotechnology, College of Biotechnology, Al-Qasim Green University, Babylon, Iraq.
  • Maher Jawad Public Health Laboratory, Babylon Health Department, Babylon, Iraq.
  • Mohammad Agresh Babel Health Directorate, Babylon Health Department, Babylon, Iraq.

Keywords:

Covid-19, Pandemic, Comorbidities, Age

Abstract

Coronavirus infection has become a major public health concern. Many studies have reported the clinical and epidemiological features of Coronavirus Disease 2019 (COVID-19), but the data remained inconsistent. This study aimed to study more available data to provide clearer picture to understand the characteristics of coronavirus patients. A total of 210 confirmed Covid-19 patients were included in this study. Data were collected during March 25th to June 24th and the impact of age, comorbidities, gender, contact, travel history, job title, contacts, on the dynamic profile of signs and symptoms in Covid-19 patients were investigated. Results showed that the patients in the age range of <10 - 29 years were mostly asymptomatic. Mild and severe symptoms were the most common in patients aged from 29 to 59 years. (10.63%) of patients aged from 60 to 69 years were asymptomatic and (5.66%), (2.70%), (3.84%) of patients were falling with the simple, mild symptoms, and sever symptoms respectively. Additionally, results showed that there was a significant difference between patients without comorbidities and the severity of COVID-19 infection. Also, there was a substantial association (p >< 0.000) between individuals’ contacting confirmed COVID-19 patients and the incidence of infections. In summary, the clinical and epidemiological features of Covid-19 patients were non-specific and heterogeneous. The information provided in this study important for understanding the impact of Covid-19

References

Donnelly, C.A., et al., Epidemiological determinants of spread of causal agent of severe acute respiratory syndrome in Hong Kong. The Lancet, 2003. 361(9371): p. 1761-1766.

Cauchemez, S., et al., Middle East respiratory syndrome coronavirus: quantification of the extent of the epidemic, surveillance biases, and transmissibility. The Lancet infectious diseases, 2014. 14(1): p. 50-56.

Wu, P., et al., Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020. Eurosurveillance, 2020. 25(3): p. 2000044.

Hamming, I., et al., Tissue distribution of ACE2 protein, the functional receptor for SARS coronavirus. A first step in understanding SARS pathogenesis. The Journal of Pathology: A Journal of the Pathological Society of Great Britain and Ireland, 2004. 203(2): p. 631-637.

COVID, C., et al., Severe outcomes among patients with coronavirus disease 2019 (COVID-19)—United States, February 12–March 16, 2020. Morbidity and mortality weekly report, 2020. 69(12): p. 343.

Zou, L., et al., SARS-CoV-2 viral load in upper respiratory specimens of infected patients. New England Journal of Medicine, 2020. 382(12): p. 1177-1179.

Rothe, C., et al., Transmission of 2019-nCoV infection from an asymptomatic contact in Germany. New England journal of medicine, 2020. 382(10): p. 970-971.

Singh, A.K., et al., Diabetes in COVID-19: Prevalence, pathophysiology, prognosis and practical considerations. Diabetes & Metabolic Syndrome: Clinical Research & Reviews, 2020. 14(4): p. 303-310.

Meng, Y., et al., Sex-specific clinical characteristics and prognosis of coronavirus disease-19 infection in Wuhan, China: A retrospective study of 168 severe patients. PLoS pathogens, 2020. 16(4): p. e1008520.

Dudley, J.P. and N.T. Lee, Disparities in age-specific morbidity and mortality from SARS-CoV-2 in China and the Republic of Korea. Clinical Infectious Diseases, 2020. 71(15): p. 863-865.

Mueller, A.L., M.S. McNamara, and D.A. Sinclair, Why does COVID-19 disproportionately affect older people? Aging (Albany NY), 2020. 12(10): p. 9959.

Ejaz, H., et al., COVID-19 and comorbidities: Deleterious impact on infected patients. Journal of infection and public health, 2020.

Clark, C.E., et al., COVID-19 and hypertension: risks and management. A scientific statement on behalf of the British and Irish Hypertension Society. Journal of Human Hypertension, 2021. 35(4): p. 304-307.

Beltramo, G., et al., Chronic respiratory diseases are predictors of severe outcome in COVID-19 hospitalised patients: a nationwide study. European Respiratory Journal, 2021.

Bwire, G.M., Coronavirus: why men are more vulnerable to Covid-19 than women? SN comprehensive clinical medicine, 2020. 2(7): p. 874-876.

Downloads

Published

2021-12-28

How to Cite

Nawar Al-Janabi, Mohanad Jawad, Abbas abed Sharhan, Zahraa M. Madani, Maher Jawad, & Mohammad Agresh. (2021). CLINICAL AND EPIDEMIOLOGICAL FEATURES OF 210 COVID-19 PATIENTS IN BABYLON GOVERNORATE DURING 2020. World Bulletin of Public Health, 5, 86-92. Retrieved from https://scholarexpress.net/index.php/wbph/article/view/408

Issue

Vol. 5 (2021): WBPH

Section

Articles

License

Creative Commons License

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.